Serum CCL7 Is a Novel Prognostic Biomarker of Metastatic Colorectal Cancer
Sign Up to like & getrecommendations! Published in 2022 at "AntiCancer Research"
DOI: 10.21873/anticanres.16139
Abstract: Background/Aim: Colorectal cancer is the third most common cancer globally, and the poor prognosis of patients with metastatic colorectal cancer (mCRC) warrants urgent attention. We previously obtained 10 candidate serum biomarkers for mCRC. Our aim… read more here.
Keywords: serum; serum ccl7; concentration; colorectal cancer ... See more keywords